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Abstract
We study whether and how physicians respond to nancial incentives, making use of
detailed register data on the health-care services provided to patients by general practitioners
(GPs) in Norway over a six-year period (2006-11). To identify GPstreatment responses,
we exploit that specialisation in general medicine entitles the GPs to a higher consultation
fee, implying a change in total and relative fee payments. To control for demand and supply
factors related to becoming a specialist, we estimate a GP xed e¤ect model focusing on a
narrow time window around the date of specialist certication. Our results show a sharp
response by the GPs immediately after obtaining specialist certication and thus a higher
consultation fee: the number of visits increase, while the treatment intensity (prolonged
consultations, lab tests, medical procedures) decline. These ndings are consistent with a
theory model where (partly) prot-motivated GPs face excess demand and income e¤ects
are su¢ ciently small. Finally, we nd no evidence for adverse health e¤ects (measured by
emergency care centre visits) on patients due to the change in GPs treatment behaviour
after becoming a specialist.
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1 Introduction
Volume-based payment schemes for health care provision have become increasingly popular
among policy makers.1 Critics argue that such schemes lead to over-provision of health care and
possibly supplier-induced demand, which result in excessive health expenditures without much
gains to patientshealth. However, proponents argue that the provider incentives generated by
volume-based payment schemes are necessary for an e¢ cient supply of health care and result in
substantial health gains to patients. Knowledge about (whether and) how health care providers
respond to nancial incentives is therefore of great importance for the design of health policy.
In this paper we study the impact of fee-for-service payments on the provision of health care
by General Practitioners (GPs). While there is a large economic literature on this topic, our
paper makes use of a unique data set and o¤ers a novel approach to identifying the e¤ects of fee
changes on GPsprovision of care. From administrative registry data, we obtain a panel data
set covering all fee-for-service payments to GPs in Norway over the six year period 2006-11. To
identify the e¤ect of fee changes on the GPsprovision of care, we exploit variation related to
specialisation in general medicine, which entitles the GPs to a higher consultation fee leaving the
fees for other services unchanged. Since GPs become specialists at di¤erent dates, this approach
gives us variation in the fee schedule over time and across GPs in terms of absolute and relative
fee levels. To identify the causal e¤ect of the fee-for-service payment, we focus on the GPs
health care provision in a narrow time window around the date of specialisation. In this short
period it is not likely that much else than the change in the consultation fee a¤ects the GPs
treatment decisions.
Estimating a GP xed-e¤ect model controlling for observable GP and patient characteristics,
our results show that the GPs change their treatment behaviour drastically after receiving the
specialist certication. In particular, we nd that the higher consultation fee associated with
specialisation leads to a strong, positive e¤ect on the number of consultations, but has a negative
e¤ect on treatment intensity (measured by laboratory tests, medical procedures or prolonged
consultations). Despite the reduction in treatment intensity, we nd that the total income
per consultation increases, which implies that the direct e¤ect of the higher consultation fee
dominates.
1Two key examples of volume-based payments schemes are fee-for-service (FFS) payments for physician services
and diagnosis-related group (DRG) pricing for hospital services. Both schemes are widely used in almost every
OECD country.
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According to our theory model, these results are consistent with treatment decisions by
prot-motivated GPs. A purely altruistic GP, which is a perfect agent for the patients, would
not change treatment behaviour according to changes in the fee-for-service schedule. However,
we show that a (partially) prot-motivated GP responds to a higher consultation fee by treating
more patients, but with a lower treatment intensity, given that physician income e¤ects are
su¢ ciently small. The reason for this is two-fold. First, a higher consultation fee implies a
change in relative prices (fees), making consultations more protable relative to services related
to the intensity of treatment. Second, the extra time spent on consultations implies that the
marginal cost of medical treatments becomes higher due to the GPstime constraint. In other
words, the change in the fee schedule due to specialisation has a positive e¤ect on the extensive
margin (the number of patients treated), but a negative e¤ect on the intensive margin (the
amount of treatment per patient).
Having found that nancial incentives inuence the GPs medical treatment, a natural ques-
tion is whether this has any impact on patientshealth outcomes. Using emergency care centre
visits shortly after a GP consultation as a measure of adverse health outcomes, we nd no (pos-
itive or negative) e¤ects after the GPs become specialists. In terms of policy implications, this
result suggests that the higher consultation fee for specialists has a negative welfare e¤ect since
it increase the medical expenditures signicantly without improving patientshealth. However,
our measure of health e¤ects may be imprecise, implying that this particular result must be
interpreted carefully.2
As mentioned above, there is a vast empirical literature on physician responses to nancial
incentives. The strand of this literature more closely related to the present paper is the one
analysing the e¤ect of fee changes on physicianssupply of medical services. The overall picture
from this literature is somewhat mixed, although many studies nd a positive supply response
to higher fees. For example, studying the e¤ects of changes in US Medicare fees, Hadley and
Reschovsky (2006) nd that a higher fee increases both the number of patients treated and
service intensity. Similarly, Clemens and Gottlieb (2014) nd strong positive supply e¤ects of
US Medicare fee increases. Using data from Canada, Kantarevic et al. (2008) also nd mostly
positive e¤ects of fee increases on the supply of medical services. Furthermore, both Epstein and
2Note that we do not analyse the e¤ects of GPs undertaking training to become specialists, which we believe
improve GPsskills and thus have positive impact on patientshealth. We use specialisation only as an instrument
for fee changes, and control for GPsinvestment in human capital by focusing on a narrow time window around
the date for specialist certication.
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Johnson (2012) and Iizuka (2007) nd some evidence of drug choice based on the prescribing
physicians nancial incentives in the US and Japan, respectively. On the other hand, Carlsen
et al. (2003) nd little or no e¤ect of fee changes on the supply of laboratory tests in Norway.
The results are considerably weaker (and more mixed) regarding cross-price e¤ects on the
supply of medical services; that is, the extent to which a fee change for a particular service
leads to adjustments in the supply of other services. For example, the aforementioned study by
Kantarevic et al. (2008) nd mostly insignicant cross-price e¤ects. Also using Canadian data,
Hurley and Labelle (1995) nd relatively weak and mixed evidence on a relationship between
relative fees and the supply of medical services. Tai-Seale et al. (1998) conducts a specic
empirical test of the McGuire-Pauly model3 on US Medicare data and nd some evidence of
negative cross-price elasticities but overall quite mixed results.
A related strand of this literature consists of papers studying the e¤ects of di¤erent physician
payment schemes, usually fee-for-service contracts versus xed-salary contracts. Also here the
results are somewhat mixed. Using Canadian data, Devlin and Sarma (2008) nd that fee-
for-service leads to more patient visits, whereas Sørensen and Grytten (2003) nd that fee-for-
service increases service production by 20-40% in Norway, compared with a xed-salary contract.
A higher supply of medical services under fee-for-service is also conrmed experimentally by
Hennig-Schmidt et al. (2011). On the other hand, Sarma et al. (2010) nd no e¤ect of fee-
for-service on total hours worked by physicians in Canada, and, based on a eld experiment
in the UK, Gosden et al. (2003) nd little or no signicant e¤ects of salaried contracts versus
fee-for-service.
This literature, and our paper, also relates more broadly to the huge literature on supplier-
induced demand (SID). Some early studies in this literature, e.g., Rice (1983, 1984), found quite
strong evidence of a backward bending supply curve (indicating large income e¤ects). Another
example is Gruber and Owing (1996), who found that reduction in fertility rates in the US
led to an increase in (higher-paid) caesarean section delivery and interpreted this as supplier-
inducement in response to a negative income shock. However, later studies reveal more mixed
ndings. For example, a series of papers on Norwegian data (Grytten et al, 1995; 2001; Carlsen
et al., 2003, 2011) report little or no evidence of SID.
3McGuire and Pauly (1991) present a theoretcial framework for studying physician response to changes in
relative fees, incorporating both the prot-maximisation hypothesis (zero income e¤ects) and the target income
hypothesis (income e¤ects of innite size).
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The rest of the paper is organised as follows. In Section 2 we present a theory model for
analysing the e¤ects of fee-for-service payments on GPs provision of medical treatment. In
Section 3 we present the institutional features of the Norwegian primary health care market.
In Section 4 data and some descriptive statistics are presented. In Section 5 we explain our
empirical strategy, while in Section 6 we report the results. In Section 7 we conduct several
sensitivity tests checking the robustness of our results, whereas in Section 8 we analyse potential
e¤ects on patientshealth outcomes. Finally, Section 9 concludes the paper.
2 A theoretical framework
Consider a physician that faces excess demand for medical treatment and can therefore freely
choose the number of consultations o¤ered per period.4 Let n be the number of consultations
and let s be intensity of treatment, such as consultation length, number of laboratory tests and
procedures, etc. Suppose that n and s are choice variables in the following optimisation problem
for the physician:
max
n;s

 := nb (s) + (1  )u ((p+ qs)n)  c (T (n; s)) ; (1)
where b () is a patient benet function that is increasing and strictly concave in treatment
intensity s, u () is the physicians utility of income, and c () is a strictly convex physician e¤ort
function, which depends on the time T spent by the physician on n consultations with treatment
intensity s. If we let tn measure the time spent per (standard length) consultation and ts the
time spent per unit of treatment intensity, the total time spent by the physician is given by
T = (tn + tss)n. The (regulated) prices the physician receives per consultation and per unit of
treatment intensity are given by p and q, respectively. Finally, the parameter  2 [0; 1] measures
the degree to which the physician cares about patient benet relative to own income. The case
of  = 1, in which the physician decides on the optimal treatment supply (n and s) solely by
trading o¤ patient benet against costs of treatment, can be interpreted as the physician being
a perfect agent for the patient. At the other extreme, where  = 0, the physician does not care
about patient benet and decides on the optimal treatment supply by trading o¤ own (utility
4 In markets where patients are insured (implying that copayments are zero or very low), it is reasonable to
assume, as for example Clemens and Gottlieb (2014) do, that health care quantity is mainly driven by physicians
supply decisions. Even if a physician does not face excess demand, there will in principle be some scope for
demand inducement through recall visits, for example.
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of) revenues against costs. By assuming that the utility function u () is weakly concave we also
allow for the possibility of income e¤ects (if u00 () < 0) on the physicians decision making.
The physicians optimal choices, n and s, are implicitly given by the following pair of
rst-order conditions:
@

@n
= b (s) + (1  )u0 ((p+ qs)n) (p+ qs)  c0 (T (n; s)) (tn + tss) = 0; (2)
@

@s
= n
 
b0 (s) + (1  )u0 ((p+ qs)n) q   c0 (T (n; s)) ts

= 0: (3)
We are interested in determining the e¤ect on the optimal solution of a change in the price per
consultation, p. By totally di¤erentiating (2)-(3) and applying Cramers rule, the e¤ect of a
change in the consultation price on the number of consultations is given by
@n
@p
=  (1  )n

264 u0 ()  b00 ()  c00 ()nt2s
+nu00 ()  (1  ) q2u0 () +  (p+ qs) b00 () + nts (tnq   tsp) c00 ()
375 ;
(4)
where  :=
 
@2
=@n2
  
@2
=@s2
    @2
=@n@s2 is positive by the second-order condition.
Similarly, the e¤ect of a change in p on the physicians choice of treatment intensity is given by5
@s
@p
=  (1  )

264 tsu0 () c00 ()T
 u00 ()n ((1  ) q (p+ qs)u0 () + (tnq   tsp) c00 ()T )
375 : (5)
Based on (4)-(5) we derive the following results:
Proposition 1 (i) If the physician is a perfect agent for the patient ( = 1), a change in the
price per consultation has no e¤ect on the number of consultations and the treatment intensity
o¤ered by the physician;
(ii) If the physician is not a perfect agent for the patient ( < 1), and if physician in-
come e¤ects are su¢ ciently small, a higher (lower) price per consultation leads to more (fewer)
consultations and a lower (higher) treatment intensity.
If the physician is a perfect agent for the patient, the optimal supply of consultations and
5 In both (4) and (5), we use the fact that, from (3), the optimal solution is characterised by
(1  ) qu0 () = c0 () ts   b0 () :
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treatment intensity depend only on a trade o¤ between patient utility and treatment costs,
neither of which depends on the price the physician receives per consultation. Consequently,
changes in the physician payment has no e¤ect on treatment decisions. On the other hand, if
the physician also takes into account own revenue, the optimal decision is partly determined by
the marginal revenue of increasing the number of consultation versus increasing the treatment
intensity, which in turn depends on the relative prices, p=q. A higher price per consultation (p)
increases the marginal revenue of consultations and therefore induces a prot-oriented physician
to increase the number of consultations o¤ered. The extra time spent on more consultations
implies that the marginal cost of treatment intensity increases, which, all else equal, leads to a
lower chosen treatment intensity.
The above described substitution e¤ects will determine the physician response to a consul-
tation price increase if the income e¤ects are su¢ ciently small (i.e., u00 () is su¢ ciently small in
absolute value). However, since a higher consultation price also directly increases the physicians
income, the e¤ect on the optimal choices of n and s is generally ambiguous in the presence of
su¢ ciently large income e¤ects, as illustrated by the second term in the square brackets of (4)
and (5), respectively. However, from (5) we see that a su¢ cient (but not necessary) condition
for @s=@p < 0 is tn=ts > p=q. Thus, the sign of @s=@p is always negative, even in the presence
of income e¤ects, if the relative price of consultations is not too high compared with relative
time costs. If, in addition, the physician is su¢ ciently prot-oriented (i.e., if  is su¢ ciently
low), the sign of @n=@p is also positive regardless of income e¤ects, as can be veried from (4).
3 Institutional background
Norway has a public health care system nanced through general taxation, i.e., National Health
Service (NHS), where the state is responsible for secondary care and municipalities for primary
care. GPs need a license to set up a practice and a contract with a municipality in order to o¤er
services to patients within the NHS.6 The number of GPs within each municipality is regulated
by the Directorate of Health which also certies the GPs with licenses. Thus, entry of physicians
on the primary health care market is highly regulated in Norway.
There are more than 4000 public GPs with a municipality contract (called "fastleger" in
6GPs (with a license) may of course set up a practice for serving private patients, i.e., patients that either have
private insurance or pay the full cost out-of-pocket.
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Norwegian). All individuals in Norway have the right to be listed with a public GP in their
municipality of residence. Individuals can switch GP (at most twice per calender year) within
the municipality.7 However, GPs can potentially turn down new patients if their patient list is
full. GPs are required to have at least 500 patients, but are not allowed to have more than 2500
patients. Within these boundaries, the GPs can actually decide the size of their list, and as long
as their list is not full (closed), they are obliged to accept all new patients.
Almost all (95 percent of) GPs in Norway are self-employed with private practises.8 Thus,
the GPs are residual claimants of any surpluses (or decits) related to treating patients within
the NHS. However, prices are regulated (or set in negotiations between the government and
the medical association), and cannot be set by the individual GP. The GPs receive third-party
payments that are a combination of capitation and fee-for-service. The capitation part is paid
by the municipalities, and the GPs are paid a at payment per individual on their list (around
NOK 400 per year). The fee-for-service part is paid by the National Insurance Scheme, and the
GPs receive a fee per consultation and per medical procedure.
GPs may decide to become specialists in general medicine. This requires (at least) four years
full-time GP practise, two years of training and course work, as well as a certain level of practise
from working at both acute and specialist care units. Around 2/3 (approximately 2400) of the
GPs are certied as specialists in general medicine. The specialist certicate has to be renewed
every fth year, which means that some GPs may lose their certication if they do not fulll the
criteria (e.g., not su¢ cient GP practice). When GPs become a specialist in general medicine
they are entitled to a substantially higher consultation fee, while the fees for the residual GP
services, such as laboratory tests and medical procedures, are left unchanged.
The fee schedule for GP services is regulated yearly by July 1. In Figure 1 we show the
development in nominal fees for GP services over the period studied. The consumer price index
is included for comparison.9 We see that the basic consultation fee has not quite caught up with
consumer prices, whereas the additional consultation fees, both for prolonged consultations and
7Of course, if individuals move to another municipality they are also allowed to switch GP across municipalities.
8The residual ve percent of the GPs are basically publicly employed with regular salary contracts.
9The consumer price index is from Statistics Norway (www.ssb.no).
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consultations with a GP specialist, have risen sharply during our sample period.10
[ Figure 1 ]
4 Data and descriptive statistics
In order to examine whether GPs respond to nancial incentives, we apply Norwegian admin-
istrative registry data from several sources. From the KUHR register, we obtain information
about the fee-for-service payments to GPs from the National Insurance Scheme.11 Since there
are specic tari¤s for each service, we observe the medical treatment provided to each patient,
including medical procedures, laboratory tests, prolonged consultations, etc. We also observe the
number of patient visits and the GPs total income per visit, as well as patient characteristics,
such as age, gender and diagnosis.
To identify whether the GP is a specialist in general medicine or when he or she becomes
such a specialist, we make us of the fee-for-service information in the KUHR register. Since
the GP specialists are entitled to an additional consultation fee, we observe whether the GP
is a specialist or the date the GP e¤ectively becomes a specialist. GP characteristics, such as
age and gender, are found in the GP database (Fastlegedatabasen), which also includes yearly
information about the GPs patient list, such as number of patients enlisted and vacant slots.
The data sources mentioned above cover all GPs and virtually all GP consultations and
services rendered.12 We apply information for the years 2006-2011. From these data sources, we
construct a GP panel data set with monthly observations. Using the information about GPs
specialist status, we dene three categories of GPs: the Always, Never and Becomes
specialist groups. In the "Becomes" specialist group, we restrict the sample to GPs that have
practiced actively at least one month before and at least one month after specialist certication
is granted. In a sensitivity test, we use a fourth category consisting of GPs who lose their
specialist status for a temporary period.
10The fees for laboratory tests and medical producedures are numerous and therefore not possible to depict
over time.
11KUHR (Kontroll og utbetaling av helserefusjon) is a public register administrated by the Norwegian Health
Administration (HELFO), which is a subordinate of the Directorate of Health. This register contains also fee-
for-service payments to other private health care providers such as specialist doctors, dentists, physiotherapists,
etc.
12Reimbursement claims are almost exclusively sent electronically. Claims sent on paper are not included in
the registry data, but amounted to merely 1 percent of all claims in 2010 (www.ssb.no/helse/statistikker/).
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Our two main outcome variables are the number of consultations and treatment intensity.
The former is measured by the variable Visits, which is the monthly number of consultations
at the GPs o¢ ce. The latter is captured by three di¤erent variables: (i) LongCons is the
proportion of the GPs consultations that exceed 20 minutes; (ii) Labtest is the proportion of
consultations where a test is taken13; and (iii) Procedures is the average number of medical
procedures performed per consultation. In addition, we construct an outcome variable, Totalfee,
which is the average GP payment per consultation, including both the fee-for-service and possible
copayments from the patients.
Our explanatory variable of prime interest is Specialist, which takes the value one when the
GP is a specialist and zero otherwise. Control variables include GP and patient characteristics.
A description of all variables used in the estimations is found in Table 1.
[ Table 1 ]
Descriptive statistics
Descriptive statistics by GP category are shown in Table 2. Our main interest is in the
Becomes" specialist category. During our sample period from 2006 to 2011, 538 GPs obtain
specialist certication, which entitles them to a higher consultation fee. When comparing means
before and after specialist certication is obtained, we observe that "Becomes" specialists have
more consultations per month, but o¤er lower treatment intensity. The increase in Totalfee
(around NOK 105) exceeds the extra consultation fee that the GPs can charge when becoming
specialists (on average around NOK 72). Notice that these gures partly reect the increase in
the consultation fee over time (as seen in Figure 1), since we compare the GPstotal income
per consultation before and after becoming a specialist. We also observe that the number of
patients enlisted becomes slightly higher after specialisation, whereas the characteristics of the
patient population seem to be fairly constant.
[ Table 2 ]
For comparison we also include the descriptive statistics for the Alwaysand Neverspe-
13Unfortunately, we cannot identify the number of lab tests for a given consultation, only whether a lab test is
performed.
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cialist group. The most striking di¤erence between these two groups is that "Always" specialists
have more patients enlisted and more consultations per month. The Never" specialists, in turn,
o¤er more long consultations and medical procedures. As expected, "Always" specialists have
a higher income per consultation, but the average di¤erence of NOK 38 is less than the extra
specialist fee they receive (on average NOK 72). A similar pattern is present for the Temporary
non-specialistcategory.
These ndings may suggest that the GPs respond to the changes in the fee schedule related
to specialist status. However, it may also reect supply-side factors, such as the GPsskills in
medical treatment due to specialisation, or demand-side factors, such as size and composition
of the patients enlisted by the GP. In order to identify the causal e¤ects of nancial incentives
on GPsprovision of medical care, a key challenge is to control for (observed and unobserved)
di¤erences in GP and patient characteristics. As a rst approach to limit this problem, we focus
only on the "Becomes" specialist category.
To study more closely to what extent GPs respond to nancial incentives, we consider changes
in the provision of medical care within a window 12 months before and 12 months after
specialist status is gained, normalised to the level 12 months before certication. Figure 2
depicts a sharp shift in the trend of the GPstotal income per consultation and the number
of consultations from one month before to one month after becoming a specialist. This e¤ect
appears to be instantaneous and fairly stable over time. From Figure 3 we see that treatment
intensity falls as soon as specialist certication is obtained, especially considering the frequency
of prolonged consultations and the number of procedures per consultation. Since Figure 2 and
3 are based on an unbalanced panel of GPs (see Figure A1 in the Appendix), we construct
the same gures for a balanced panel with 181 GPs present in all periods. The picture is very
similar, as shown in Figure A2 and A3 in the Appendix.
[ Figure 2 and 3 ]
However, a more thorough investigation is needed to account for factors that may a¤ect the
GPsprovision of services and possibly coincide with specialist certication, such as demand-
side factors (e.g., changes in patient population) or supply-side factors (e.g., GP skills in medical
treatment). In addition, a possible confounding factor is that becoming a specialist requires time
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and e¤ort from the GP, which might inuence the provision of medical care during the qualifying
period. In the next section, we explain our empirical strategy for dealing with these (and other)
issues.
5 Empirical strategy
Our empirical strategy for identifying the GPsresponses to nancial incentives is to compare
the provision of medical care in a narrow windowaround the date the GP becomes a specialist
in general medicine from three months before to three months after the date of certication.
The identifying assumption is that within such a short period, there are no changes (other than
the specialist fee) that cannot be controlled for and that may a¤ect treatment in a signicant and
systematic manner. Focusing on a short period, we control for all demand and supply changes
that may inuence the GPshealth care provision, such as changes the GPshuman capital or
the size and composition of the patient population. In this way, we can identify the causal e¤ect
of the fee changes on the GPs medical treatment holding all other factors constant.
In the analysis we restrict the sample to the "Becomes" specialist group only, excluding the
GPs that are "Always" or "Never" specialists. Since we do not use other GPs as controls, this
implies that the counterfactual situation is represented by the "treated" GPsmedical treatment
in the period just before their specialist certication. Moreover, since the GPs continuously
become specialists at di¤erent dates over the observational period, it is unlikely that other factors
coincide with becoming a specialist, and therefore unnecessary to use "Always" or "Never"
specialists as a control group.14
Our empirical strategy ensures internal validity, but may raise a concern about external
validity. The GPs that become specialists may di¤er from the non-specialists on unobservable
characteristics that can be related to our outcome variables, for instance, regarding prot-
motivation or degree of altruism. However, as shown in Figure A4 in the Appendix, the large
majority (more than 80 percent) of the GPs become specialists during their career, and are thus
highly representative for the population of GPs.
Our main specication is a model with xed-e¤ects at the GP level as presented below, where
14For sensitivity tests, we estimate models using the "Always" and "Never" specialist categories as control
groups. The results are qualitively similar and available upon request.
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the subscripts i, j and t represents GP, calender month, and year, respectively:
Yijt = 0 + 1Specialistijt + 2GPijt + j + t + i + "ijt (6)
The dependent variable Y represents the GPsmedical treatment measured by either the num-
ber of visits, the treatment intensity (rate of prolonged consultations, rate of laboratory tests,
number of medical procedures), or the total fee earned per consultation; see Table 1 for a closer
description. When estimating outcomes that reect treatment intensity, the number of visits
is included as control. The parameter of interest is 1, which represents the change in Y from
the pre to the post certication period. The vector GP comprises characteristics of the GPs
patient population, including age, gender and comorbidity of visiting patients, and (yearly in-
formation about) the number of patients enlisted. The xed-e¤ect  captures time-invariant
GP characteristics, whether observable (such as gender, year of birth) or unobservable (e.g.,
altruism, prot-motivation, skills, etc.). Finally, we include month and year dummies to control
for seasonal variation and time trends, whereas " is an error term. All models are estimated
with robust standard errors.
6 Results
Becoming a specialist in general medicine substantially increases the fee for consultations (more
than 60 percent), but does not a¤ect the fees for other GP services. Thus, the GP specialist
status changes both the total and the relative fee payments. As shown in the theory section, the
GPsresponse to such a change in nancial incentives depends on the degree of prot motivation
relative to altruism. If the GP is a perfect agent for the patient, we expect no response to the
extra specialist fee for consultation. However, if the GP is (to some extent) motivated by prots,
the theory model predicts that the higher consultation fee leads to more consultations and lower
treatment intensity, under the assumption of su¢ ciently small income e¤ects.
In our empirical analysis we aim at testing these theoretical predictions by controlling for
relevant factors other than nancial incentives that might a¤ect the GPstreatment decisions.
Our main results are reported in Table 3.
[ Table 3 ]
13
The results show that GPs who become specialists change their service pattern profoundly from
three month prior to certication to three month after certication. We estimate the impact
of specialist status for ve di¤erent outcomes reported in separate columns. After obtaining
specialist certication, the GPs increase the number of visits per month by 19:5 on average, but
reduce the treatment intensity per visit: the rate of prolonged consultations and laboratory tests
are decreased by 3:2 and 1:0 percentage points, respectively, while the average number of medical
procedures per consultation falls by about 0:02. Despite the decrease in treatment intensity, the
total fee per consultation rises (with about NOK 61). Thus, the increase on consultation fee
due to specialisation dominates the reduction in treatment intensity. Some of these e¤ects are
small in absolute values, but compared to pre-certication levels of the Becomesgroup, they
are of considerable magnitude. Total fee per consultation rises by 28 percent, the number of
visits increases by 9 percent, and treatment intensity falls by 2   10 percent depending on
which outcome is considered. Except for lab tests, all e¤ects mentioned above are statistically
signicant at least at the one percent level.
Since we apply a xed-e¤ect model, the estimated parameters for our variables show how
individual GPs on average respond to changes over time. From Table 3, we see that the e¤ects
of patient population characteristics (i.e., age, gender and comorbidity) are mostly insignicant
and/or small. This is as expected given the small variation in patient population from the pre-
to the post-certication period.
7 Sensitivity analysis
7.1 Narrowing the time window
A potential concern with our empirical strategy is that the GPs expend e¤ort in the pre-
certication period in order to qualify for specialisation. Thus, the nding that the number
of visits increases sharply from three months before to three months after specialist certication
could potentially be explained by such time-consuming e¤ort. However, this cannot explain that
GPs reduce the treatment intensity after receiving specialisation. Moreover, since the approval
of specialisation by the medical association usually takes two to three months, the GPs are not
likely to undertake time-consuming training in the short three month period before receiving the
certication. To ensure that this not a problem to our results, we conduct a sensitivity test by
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reducing the time window to one month before and after certication using the same empirical
specication as in (6).
[ Table 4 ]
As shown in Table 4, the results are almost identical to the results using a three month
period before and after specialisation. Since the GPs do not expend training e¤ort the month
before receiving certication, these results conrm that the changes in GPsmedical treatment
behaviour are due to the total and relative fee changes related to becoming a specialist.
The fee schedule is changed annually by 1st of July. This implies that the GPs that become
specialists in June or July are exposed to the revision of the fee schedule in addition to the
change in consultation fee for specialists. To check whether our results are a¤ected by this, we
exclude all GPs becoming specialist in these two months. From the lower section of Table 4,
we see that the results are almost identical, except for a stronger e¤ect on the number of visits
(now 24:6, while before 19:3).
7.2 Extending the time window
An interesting question is whether the e¤ects reported in Table 3 are just short term or actually
represents a persistent shift in the GPsprovision of health care. To investigate this question,
we include observations for the Becomes specialistgroup from three months up to 24 months
after certication. Results are reported in Table 5.
[ Table 5 ]
Although we observe minor changes in the e¤ects as the after-certication period is extended,
the results show the same overall picture as described above: after specialist certication, GPs
increase their number of visits and decrease treatment intensity. Thus, the results in Table 5
increases our condence in the main results that GPs respond to a higher consultation fee due
to specialist certication, and that this e¤ect is persistent over time.
7.3 Temporary non-specialists
In our data there are some GPs that temporarily lose their specialisation. This enables us to
conduct a sensitivity test, where we investigate whether these GPs respond in the same way to
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nancial incentives as the "Becomes" specialists. When estimating the e¤ects, we include only
GPs who lose their specialist certication and then regain it during our observation period. This
gives a sample of 54 GPs, dened as the Temporary non-specialistcategory in Section 4.
Since the number of GPs that temporarily lose their specialisation is fairly small, we use
a di¤erence-in-di¤erences approach with the "Always specialists" as a comparison group rep-
resenting the counterfactual situation. To identify the e¤ect of fee changes due to (losing)
specialisation, we include two dummy variables: (i) NonSpec which takes the value one in the
periods when the GPs temporarily lose their specialist certication; and (ii) Post NonSpec which
takes the value one in the periods after the GPs regain their specialist certication.
[ Table 6 ]
We nd that in the period after loss of certication, GPs have fewer consultations and higher
treatment intensity than they had when they were remunerated as specialists. These results
are consistent with our results reported in Tables 3 and 4. When GPs regain their specialist
certication, their medical treatment pattern is almost identical as before their certication
was lost. The estimated parameters for the Post NonSpec variable are either insignicant or
ignorable in magnitude, with the exception that the number of procedures per consultation has
increased.
8 Patientshealth outcomes
Having found that GPs change their medical treatment pattern due to changes in the fee-for-
service schedule, a natural question is whether this has as any impact on the patientshealth.
To investigate this question, we consider whether the patients receive emergency care shortly
after visiting the GP. We believe this measure captures adverse health e¤ects that potentially
are due to insu¢ cient treatment by the GPs. In our data we have information about all patient
visits at emergency care centres. For all patients we observe the date of the GP visit and the
date for emergency care for the patients that receive this. Based on this we dene a visit to
an emergency care centre within a week (either three or seven days) after a GP visit as an
adverse health e¤ect. In the analysis, we use the same specication as in our main model given
in (6) using all consultations three months before and after the GPs received their specialist
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certication. As reported in the table, we consider both the change in the absolute number of
emergency visits and the change in the proportion of all consultations that result in an emergency
visit within three or seven days after a GP visit.
[ Table 7 ]
As can be seen from the table, we nd no evidence for adverse health e¤ects due to the change
in the GPsmedical treatment. Thus, the GPsresponse to the change in the fee schedule does
not seem to a¤ect patients negatively. In terms of policy implications, our results suggest that
the higher consultation fee has a negative welfare e¤ect since it increase the medical expenditures
signicantly without resulting in positive health e¤ects for the patients. However, our measure
of patient health outcomes is imprecise and may not capture all relevant aspects related to the
e¤ect of the medical treatment. Thus, we cannot rule out that the change in the GPs medical
treatment after becoming specialists may involve positive (or negative) health e¤ects for their
patients.
9 Concluding remarks
In this paper we provide evidence that physicians respond to nancial incentives. Using rich
register data, we employ a panel data set covering all patient visits to GPs in Norway over the
six year period 2006-11. We take a novel approach to identify the causal e¤ects of changes in
the fee schedule on physicians medical treatment by focusing on GPs that become specialists
in general medicine and thus are entitled to a higher consultation fee. This approach yields
variation in the fee schedule across GPs over time due to the fact that GPs obtain certication
at di¤erent dates. Since becoming a specialist is endogenous, we estimate the e¤ects in a narrow
time window around the date of specialisation. In this short period it is not likely that much
else than the change in the consultation fee a¤ects the GPstreatment decisions.
Our results show the GPs that become a specialist in general medicine change their treatment
behaviour immediately after becoming a specialist. We nd that the higher consultation fee
associated with specialisation leads to a strong positive e¤ect on the number of consultations,
but a negative e¤ect on treatment intensity (measured by laboratory tests, medical procedures
and prolonged consultations). Despite the reduction in treatment intensity, we nd that the total
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income per consultation increases, which implies that the direct e¤ect of the higher consultation
fee dominates.
These results are consistent with a theory model with excess demand where the GPs are
partly prot motivated and income e¤ects are su¢ ciently small. In this setting, a GP would
respond to a higher consultation fee by treating more patients, but with a lower intensity of
medical treatments for two reasons: First, a higher consultation fee implies a change in relative
prices (fees), making consultations more protable relative to treatment intensity. Second, the
extra time spent on consultations implies that the marginal cost of medical treatments becomes
higher due to the GPstime constraint.
Finally, our empirical analysis nd no (positive or negative) e¤ect on patientshealth out-
comes measured by emergency care visits shortly after a GP visit. This result suggests a negative
welfare e¤ect due to the large increase in medical expenditures. However, our measure of health
e¤ects may be imprecise, implying that the result must be interpreted carefully. Moreover, we
do not study the e¤ect of becoming a specialist per se. GPs that undertake specialist training
are likely to improve their treatment skills gradually over time. However, we use only speciali-
sation as an instrument for changes in fees, and our analysis does not focus on the social value
of specialisation in general medicine.
A Appendix
[ Figure A1 to A4 ]
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TABLES		
 
Table 1. Variable definitions 
GP categories:  
Always specialist 1 if GP is registered as a specialist in general medicine for the whole period 
Never specialist 1 if GP is not registered as a specialist in any month within the observation 
period 
Becomes specialist 1 if GP becomes a specialist in general medicine within the data period 
Temporary non-
specialist 
1 in months when the GP has temporarily lost the specialist certification. 
Dependent 
variables 
 
TotalFee Average amount earned per consultation, NOK 
LongCons Prolonged consultations, rate  
LabTests Laboratory tests, rate 
Procedures Average number of procedures (per consultation) 
Visits Number of visits (consultations per month) 
Explanatory 
variables 
 
Specialist 1 in months after a GP in the becomes specialist category has gained 
specialist status 
PatAge Average age of (visiting) patients  
PatMale Proportion of male (visiting) patients 
CoMorb Proportion of (visiting) patients with a secondary diagnosis  
GPAge Age of the GP 
GPMale 1 if the GP is male 
ListLength Number of patients listed with GP, in 100s (by 1 January each year) 
NonSpec 1 in months after a GP in the temporarily non-specialist category loses 
specialist status 
Post NonSpec 1 in months after the certification has been regained by a GP in the 
temporarily non-specialist category 
 
Table 2. Descriptive statistics, means and standard deviations in parenthesis. 
 Always 
specialist 
Never 
specialist 
Becomes specialist Temporary non-
specialist 
  Before After Specialist Non-
specialist
TotalFee 286.68 
(90.69) 
248.52 
(69.75)
221.52
(71.16)
326.31 
(64.41)
290.67 
(82.52) 
260.85 
(78.89)
LongCons 0.27 
 (0.14) 
0.34 
(0.18)
0.31 
(0.15)
0.28 
(0.13)
0.31 
 (0.16) 
0.40 
(0.25)
LabTest 0.43  
(0.11) 
0.42 
(0.13)
0.41 
(0.11)
0.41 
(0.210)
0.39  
(0.12) 
0.39 
(0.12)
Procedures 0.21  
(0.13) 
0.24 
(0.18)
0.26 
(0.16)
0.25 
(0.17)
0.23  
(0.15) 
0.27 
(0.18)
Visits 265.97 
(115.41) 
229.91 
(120.61)
220.82 
(98.60)
253.03 
(112.02
265.75 
(129.05) 
219.63 
(98.88)
PatAge 47.91  
(6.60) 
46.26 
(7.70)
43.89 
(7.29)
44.69 
(6.52)
47.92  
(7.32) 
48.61 
(7.72)
PatMale 0.41 
 (0.12) 
0.41 
(0.11)
0.39 
(0.10)
0.39 
(0.10)
0.43 
 (0.10) 
0.45 
(0.09)
CoMorb 0.20  
(0.17) 
0.20
 (0.17)
0.18 
(0.14)
0.18 
(0.15)
0.22  
(0.18) 
0.25
 (0.21)
GPAge 53.52  
(6.84) 
44.24 
(10.83)
40.19 
(7.64)
43.51
 (6.90)
52.53  
(7.30) 
50.66 
(9.32)
GPMale 0.72  
(0.45) 
0.64 
(0.48)
0.62
 (0.48)
0.59 
(0.49)
0.88  
(0.32) 
0.95 
(0.20)
ListLength 1308.04 
(361.28) 
1162.67 
(402.05)
1153.81 
(320.13)
1223.18 
(331.16)
1299.09 
(409.77) 
1159.61 
(348.13)
Observations 126 014 64 252 14 188 17 835 2 808 575
GPs 1 936  1 398 538 538 54 54
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 3. GP treatment decisions, changes as specialist certification is obtained.  
 (1) (2) (3) (4) (5)
 TotalFee LongCons LabTest Procedures Visits
Specialist 61.4249*** -0.0316*** -0.0099* -0.0207** 19.4960***
 (1.8475) (0.0052) (0.0047) (0.0077) (5.2476)
      PatAge -0.7223 -0.0003 0.0033* -0.0021 -2.5543**
 (0.7850) (0.0015) (0.0014) (0.0011) (0.8912)
      PatMale -82.1155 -0.1046 0.1375 -0.0940 42.6218
 (72.8948) (0.0739) (0.0772) (0.1301) (51.6252)
      CoMorb 0.4019* 0.0007 0.0006 0.0005 -0.1207
 (0.2024) (0.0005) (0.0005) (0.0010) (0.3249)
      Visits -0.0447*** -0.0001** 0.0000 -0.0001* 
 (0.0133) (0.0000) (0.0000) (0.0000) 
      ListLength -4.7117 0.0073*** 0.0007 -0.0260 -0.8772
 (3.9336) (0.0021) (0.0035) (0.0151) (2.2092)
      Cons 386.7921*** 0.2626** 0.2193* 0.6407*** 322.0174***
 (78.8321) (0.0953) (0.0894) (0.1846) (63.7056)
Year/month fixed 
effects 
Yes Yes Yes Yes Yes
GP fixed effects Yes Yes Yes Yes Yes
Observations 3043 3043 3043 3043 3043
GPs 538 538 538 538 538
R2 0.650 0.119 0.084 0.061 0.211
Robust standard errors in parentheses, * p < 0.05, ** p < 0.01, *** p < 0.001 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 4. GP treatment decisions, analysed over a shorter pre and post certification period. 
 (1) (2) (3) (4) (5)
 TotalFee LongCons LabTestst Procedures Visits
1 months before and 1 months after 
Specialist 62.2542*** -0.0273*** -0.0106** -0.0209*** 19.2512***
 (1.3386) (0.0037) (0.0039) (0.0048) (4.0094)
Observations 1076 1076 1076 1076 1076
GPs 538 538 538 538 538
R2 0.825 0.162 0.110 0.070 0.265
1 months before and 1 months after, excluding GPs becoming specialist in June or July  
Specialist 60.5044*** -0.0322*** -0.0150** -0.0193*** 24.5853***
 (1.6366) (0.0051) (0.0049) (0.0056) (4.7190)
Observations 944 944 944 944 944
GPs 538 538 538 538 538
R2 0.834 0.169 0.125 0.070 0.282
Robust standard errors in parentheses, * p < 0.05, ** p < 0.01, *** p < 0.001. All models are estimated with GP, 
year and month fixed effects and with the same set of explanatory variables as in Table 3. 
 
 
 
 
Table 5. GP treatment decisions, analysed over a longer post certification period. 
 (1) (2) (3) (4) (5)
 TotalFee LongCons LabTestst Procedures Visits
3 months before and 6 months after 
Specialist 59.0154*** -0.0257*** -0.0116*** -0.0144** 22.7039***
 (1.5992) (0.0035) (0.0033) (0.0047) (3.7880)
Observations 4519 4519 4519 4519 4519
GPs 538 538 538 538 538
R2 0.616 0.113 0.074 0.040 0.239
3 months before and 12 months after 
Specialist 57.3149*** -0.0268*** -0.0129*** -0.0173*** 21.9896***
 (1.0752) (0.0023) (0.0022) (0.0032) (2.6151)
Observations 7175 7175 7175 7175 7175
GPs 538 538 538 538 538
R2 0.572 0.093 0.075 0.035 0.225
3 months before and 24 months after 
Specialist 56.8295*** -0.0267*** -0.0161*** -0.0175*** 20.9107***
 (0.9005) (0.0019) (0.0018) (0.0028) (2.0446)
Observations 11482 11482 11482 11482 11482
GPs 538 538 538 538 538
R2 0.522 0.071 0.066 0.028 0.227
Robust standard errors in parentheses, * p < 0.05, ** p < 0.01, *** p < 0.001. All models are estimated with GP, 
year and month fixed effects and with the same set of explanatory variables as in Table 3. 
 
 
 
Table 6. GP treatment decisions, changes for the “Temporarily non-specialist” category. 
 (1) (2) (3) (4) (5)
 TotalFee LongCons LabTestst Procedures Visits
NonSpec -52.3182*** 0.0354*** 0.0302*** 0.0271*** -34.8748***
 (1.6718) (0.0032) (0.0031) (0.0036) (3.4601)
      Post NonSpec -0.6203 -0.0054* -0.0007 0.0103*** -0.4807
 (1.2764) (0.0024) (0.0024) (0.0028) (2.6427)
      PatAge 0.6672*** 0.0019*** 0.0029*** -0.0007*** -4.8478***
 (0.0340) (0.0001) (0.0001) (0.0001) (0.0691)
      PatMale -3.6690* -0.0671*** 0.0300*** -0.0559*** 7.7112*
 (1.8359) (0.0035) (0.0034) (0.0040) (3.8011)
      CoMorb 0.0907*** 0.0009*** 0.0002*** 0.0004*** -0.2207***
 (0.0112) (0.0000) (0.0000) (0.0000) (0.0231)
      Visits -0.0244*** -0.0001*** 0.0000*** -0.0000*** 
 (0.0014) (0.0000) (0.0000) (0.0000) 
      ListLength -0.5593*** -0.0038*** 0.0014*** 0.0013*** 7.7999***
 (0.1092) (0.0002) (0.0002) (0.0002) (0.2250)
      Cons 241.2865*** 0.2641*** 0.2351*** 0.2388*** 416.7599***
 (2.3211) (0.0044) (0.0043) (0.0051) (4.6618)
Year/month fixed effects Yes Yes Yes Yes Yes
GP fixed effects Yes Yes Yes Yes Yes
Observations 129 397 129 397 129 397 129 397 129 397
GPs 1 990 1 990 1 990 1 990 1 990
R2 0.545 0.068 0.096 0.016 0.270
Robust standard errors in parentheses, * p < 0.05, ** p < 0.01, *** p < 0.001 
 
   
Table 7. Number of patients visiting an emergency care centre within 3 or 7 days. 
 (1) (2) (3) (4) 
 Number of 
patients, 
within 3 days 
Number of 
patients, 
within 7 days 
Proportion of all 
consultations, 
within 3 days 
Proportion of all 
consultations, 
within 7 days 
Specialist -0.1419 -0.0183 -0.0002 0.0001 
 (0.0797) (0.1213) (0.0004) (0.0006) 
     PatAge -0.0069 -0.0102 -0.0001 -0.0001 
 (0.0062) (0.0099) (0.0001) (0.0001) 
     PatMale 0.1791 0.0047 0.0009 0.0075 
 (0.3417) (0.5028) (0.0039) (0.0070) 
     CoMorb -0.0035 -0.0147** 0.0000 -0.0000 
 (0.0030) (0.0052) (0.0000) (0.0000) 
     Visits 0.0031*** 0.0052*** 0.0000 -0.0000 
 (0.0003) (0.0006) (0.0000) (0.0000) 
     ListLength 0.0242 0.0236 0.0001 0.0000 
 (0.0351) (0.0544) (0.0002) (0.0002) 
     Cons -0.8792 0.7591 0.0037 0.0111 
 (0.8749) (1.3429) (0.0044) (0.0074) 
Year/month fixed 
effects 
Yes Yes Yes Yes 
GP fixed effects Yes Yes Yes Yes 
Observations 3043 3043 3043 3043 
GPs 538 538 538 538 
R2 0.058 0.072 0.015 0.018 
 
 
 
 
 
 
 
 
 
 
FIGURES	
 
 
Figure 1. GP fees over time, nominal terms, with 2005 as base year (www.lovdata.no). In 
Norwegian kroner (NOK) the fees as of July 2005 are as follows: basic consultation fee NOK 
125, long consultation fee NOK 100, and extra specialist fee NOK 61.  
 
 
Figure 2.Total fee per consultation and number of visits per month, means taken over all GPs 
in the estimated sample who become specialists within the period studied. 
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Figure 3. Treatment intensity over time. Means are taken over all GPs in the estimated sample 
who become specialists within the period studied. 
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FIGURES	APPENDIX	
 
  
Figure A1. Number of GPs in the “ Becomes” group who are included in the data. The 
horizontal axis shows month relative to month of certification. 
 
 
 
Figure A2. Total fee per consultation and number of visits per month, relative to month of 
certification. Means taken over all GPs in the estimated sample who become specialists within 
the period studied and are present in the data for all 25 months. 
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Figure A3. Treatment intensity relative to month of certification. Means taken over all GPs in 
the estimated sample who become specialists within the period studied and are present in the 
data for all 25 months. 
 
 
 
Figure A4. The proportion of GPs who are certified as specialist, by age groups. 
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